Ning Li

4.5k total citations
164 papers, 2.4k citations indexed

About

Ning Li is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ning Li has authored 164 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 58 papers in Molecular Biology and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ning Li's work include Lung Cancer Treatments and Mutations (32 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Cancer Genomics and Diagnostics (24 papers). Ning Li is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Cancer Genomics and Diagnostics (24 papers). Ning Li collaborates with scholars based in China, United States and Australia. Ning Li's co-authors include Shuhang Wang, Peiwen Ma, Huilei Miao, Huiyao Huang, Yan Zha, Yuan Fang, Shujun Xing, Qiyu Tang, Ning Jiang and Kun Chen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ning Li

148 papers receiving 2.3k citations

Peers

Ning Li
Rishi Surana United States
Jonathan Carlson United States
Olivier D. Christophe France
Kalevi Kairemo Finland
Eduardo Castañón Spain
Mark M. Fuster United States
Paul Cozzi Australia
Lianhong Li China
Ivan M. Blasutig Canada
Vanessa M. Hubbard-Lucey United States
Rishi Surana United States
Ning Li
Citations per year, relative to Ning Li Ning Li (= 1×) peers Rishi Surana

Countries citing papers authored by Ning Li

Since Specialization
Citations

This map shows the geographic impact of Ning Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Li more than expected).

Fields of papers citing papers by Ning Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Li. The network helps show where Ning Li may publish in the future.

Co-authorship network of co-authors of Ning Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Li. A scholar is included among the top collaborators of Ning Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Li. Ning Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Ming-Hong, et al.. (2025). SHOX2 and RASSF1A methylation in diagnosing malignant pleural effusion induced by lung cancer. Clinica Chimica Acta. 572. 120273–120273.
2.
Guo, Zhao, et al.. (2025). Watershed year of cell and gene therapy (CGT): A review of 2024 CGT approvals. Cancer Letters. 632. 217980–217980.
3.
Li, Ning, et al.. (2025). Whole blood exchange ameliorates acute hemolytic anemia by reducing inflammation and oxidative stress in rats. The FASEB Journal. 39(2). e70358–e70358. 1 indexed citations
4.
Zhou, Xingyu, Yuan Fang, Peiwen Ma, et al.. (2025). Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy. Med. 6(10). 100849–100849. 1 indexed citations
5.
Guo, Zhao, Yuning Wang, Shujun Xing, et al.. (2024). Exosome-based anticancer vaccines: From Bench to bedside. Cancer Letters. 595. 216989–216989. 22 indexed citations
6.
Huang, Dongdong, et al.. (2024). Artificial intelligence in lung cancer: current applications, future perspectives, and challenges. Frontiers in Oncology. 14. 1486310–1486310. 17 indexed citations
7.
Guo, Zhao, Yuanting Cai, Yuning Wang, et al.. (2024). Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study. The Journal of Gene Medicine. 26(5). e3691–e3691. 3 indexed citations
8.
Huang, Huiyao, Ning Jiang, Wenting Chen, Yu Tang, & Ning Li. (2024). A call to rethink the necessity of and challenges facing academic research organizations in the new era of drug innovation in China. Drug Discovery Today. 29(4). 103925–103925. 2 indexed citations
9.
10.
Wu, Dawei, Shujun Xing, Xin Wang, et al.. (2024). Personalized neoantigen cancer vaccines: current progression, challenges and a bright future. Clinical and Experimental Medicine. 24(1). 229–229. 17 indexed citations
11.
Wang, Shuhang, et al.. (2024). Mobilizing China and the Global Community to Confront the Treatment Desert for Pediatric Solid Tumors. Cancer Discovery. 14(1). 26–29. 3 indexed citations
12.
Huang, Huiyao, Yu Tang, Dawei Wu, et al.. (2023). Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution. BMC Geriatrics. 23(1). 195–214. 4 indexed citations
13.
Jiang, Ning, Yue Yu, Dawei Wu, et al.. (2023). HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events. Journal of Cancer Research and Clinical Oncology. 149(2). 737–747. 19 indexed citations
14.
Liu, Xin, Yong Yang, Shulian Wang, et al.. (2022). Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy. Journal of Cancer Research and Clinical Oncology. 149(8). 5219–5230. 2 indexed citations
15.
Wang, Lin, Yun Jiang, Haoran Cheng, et al.. (2021). Nanoscopic wear behavior of dentinogenesis imperfecta type II tooth dentin. Journal of the mechanical behavior of biomedical materials. 120. 104585–104585. 5 indexed citations
16.
Huang, Huiyao, Huilei Miao, Jun Wang, et al.. (2021). Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approval. SHILAP Revista de lepidopterología. 1(4). 147–152. 10 indexed citations
17.
Li, Ning, Fengwei Tan, Bin Qiu, et al.. (2018). [Comparison of lung cancer surgery in China, 2005 vs. 2015].. PubMed. 40(4). 300–302. 2 indexed citations
18.
19.
Zhou, Fei, Ning Li, Weihua Jiang, et al.. (2012). Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial. World Journal of Surgical Oncology. 10(1). 274–274. 35 indexed citations
20.
Wei, Zhiguo, Qian Wu, Liming Ren, et al.. (2009). Expression of IgM, IgD, and IgY in a Reptile, Anolis carolinensis. The Journal of Immunology. 183(6). 3858–3864. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rishi Surana Breakdown of academic impact, for papers by Jonathan Carlson Breakdown of academic impact, for papers by Olivier D. Christophe Breakdown of academic impact, for papers by Kalevi Kairemo Breakdown of academic impact, for papers by Eduardo Castañón Breakdown of academic impact, for papers by Mark M. Fuster Breakdown of academic impact, for papers by Paul Cozzi Breakdown of academic impact, for papers by Lianhong Li Breakdown of academic impact, for papers by Ivan M. Blasutig Breakdown of academic impact, for papers by Vanessa M. Hubbard-Lucey
Rankless by CCL
2026